Literature DB >> 3130212

Aurothioglucose overdosage in five patients with rheumatoid arthritis.

I Rubinstein1, P Langevitz, M Pras.   

Abstract

Five patients with active seronegative, rheumatoid arthritis, HLA-DR3 negative, received inadvertently 250 to 500 mg of aurothioglucose instead of their usual weekly dose, during standard remission-inducing chrysotherapy. Subsequently a rapid and sustained clinical remission appeared in all five patients.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3130212     DOI： 10.1007/bf02330597

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  24 in total

1.  Gold overdose treated with BAL.

Authors:  T W Bunch
Journal:  Arthritis Rheum       Date:  1976 Jan-Feb

2.  Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion.

Authors:  N L Gottlieb; P M Smith; E M Smith
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

3.  Case reports. Severe enterocolitis complicating chrysotherapy.

Authors:  N Kaplinsky; M Pras; O Frankl
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

Review 4.  The treatment of rheumatoid arthritis with gold.

Authors:  G B Bluhm
Journal:  Semin Arthritis Rheum       Date:  1975-11       Impact factor: 5.532

5.  Fatal intrahepatic cholestasis and interstitial lung fibrosis following gold therapy for rheumatoid arthritis.

Authors:  M R Shaban; D N Golding; R G Letcher
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

6.  Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.

Authors:  R C Gerber; H E Paulus; R I Jennrich; M Lederer; R Bluestone; W H Blahd; C M Pearson
Journal:  J Lab Clin Med       Date:  1974-05

7.  Delayed thrombocytopenic purpura after diminutive gold therapy.

Authors:  J R Saphir; R G Ney
Journal:  JAMA       Date:  1966-02-28       Impact factor: 56.272

8.  Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.

Authors:  J S Lawrence
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

9.  A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis.

Authors:  D E Furst; S Levine; R Srinivasan; A L Metzger; R Bangert; H E Paulus
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

10.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11
View more
  6 in total

1.  Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.

Authors:  Stefanie Prast-Nielsen; Thomas S Dexheimer; Lena Schultz; William C Stafford; Qing Cheng; Jianqiang Xu; Ajit Jadhav; Elias S J Arnér; Anton Simeonov
Journal:  Free Radic Biol Med       Date:  2011-01-22       Impact factor: 7.376

2.  Disease-modifying drugs for rheumatoid arthritis. Asset or liability?

Authors:  H A Bird
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

3.  Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.

Authors:  Qian Li; Stephanie B Wall; Changchun Ren; Markus Velten; Cynthia L Hill; Morgan L Locy; Lynette K Rogers; Trent E Tipple
Journal:  Am J Respir Cell Mol Biol       Date:  2016-09       Impact factor: 6.914

Review 4.  The thioredoxin system in neonatal lung disease.

Authors:  Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

5.  The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.

Authors:  Rodney D Britt; Markus Velten; Morgan L Locy; Lynette K Rogers; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

6.  Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation.

Authors:  Bernadette Chen; Viktoria E Nelin; Morgan L Locy; Yi Jin; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.